A highly active and negatively charged Streptococcus pyogenes lysin with a rare D-alanyl-L-alanine endopeptidase activity protects mice against streptococcal bacteremia.
about
Antimicrobial bacteriophage-derived proteins and therapeutic applicationsBacteriocin protein BacL1 of Enterococcus faecalis targets cell division loci and specifically recognizes L-Ala2-cross-bridged peptidoglycan.Novel phage lysin capable of killing the multidrug-resistant gram-negative bacterium Acinetobacter baumannii in a mouse bacteremia model.Prophage lysin Ply30 protects mice from Streptococcus suis and Streptococcus equi subsp. zooepidemicus infections.Using a Novel Lysin To Help Control Clostridium difficile InfectionsDetermining bacteriophage endopeptidase activity using either fluorophore-quencher labeled peptides combined with liquid chromatography-mass spectrometry (LC-MS) or Förster resonance energy transfer (FRET) assaysPhage lytic proteins: biotechnological applications beyond clinical antimicrobials.Bacteriophages and their derivatives for the treatment and control of food-producing animal infections.A novel prophage lysin Ply5218 with extended lytic activity and stability against Streptococcus suis infection.A novel endolysin disrupts Streptococcus suis with high efficiency.The essential protein for bacterial flagella formation FlgJ functions as a β-N-acetylglucosaminidase.Recombinant Endolysins as Potential Therapeutics against Antibiotic-Resistant Staphylococcus aureus: Current Status of Research and Novel Delivery Strategies.The molecular mechanism of N-acetylglucosamine side-chain attachment to the Lancefield group A carbohydrate in Streptococcus pyogenes.Alternative therapeutics for self-limiting infections-An indirect approach to the antibiotic resistance challenge.Applications of bacteriophages versus phage enzymes to combat and cure bacterial infections: an ambitious and also a realistic application?Phage Lysins for Fighting Bacterial Respiratory Infections: A New Generation of Antimicrobials
P2860
Q26781115-4B09C72C-F54C-459B-9211-F9D8FBACD008Q30009288-F4860866-6075-4B14-8F84-431EABA32516Q35168859-F55C6B03-C6C9-4F62-9FF7-1F1EC6B174ECQ36119542-C501AF2A-D074-4C0C-A4DF-DDEC3EF4468CQ36290571-D0363E06-BE79-40F7-AD88-F6AE7CDA7A36Q36309151-2F606A16-9083-45E3-AF30-1CD56E0352EFQ38325227-E61540D8-7A9F-439A-9F0D-584AF9517B6AQ39029801-2C377248-973A-4FAB-864B-26E557C581D6Q39535283-4DB43BEE-B9D9-4475-9D07-6A5DF0DA5296Q40327769-52B39CAE-449D-477C-B39A-84AAD22B41EFQ42155219-1E6CEFED-26FA-459F-90E2-38A5DF298305Q46251747-741AE38E-A2DC-472B-9ED6-9FA22C4F8AAFQ46288769-58B1F4F8-9716-4143-A62E-AA4E72BD03E4Q47284987-EC20B325-8D44-4EE6-9459-52AFC2E12F29Q50016951-653CF00F-5A16-44D5-AD44-697D08948901Q59128002-8CE1BA23-AB58-4C95-84C0-7398546B1076
P2860
A highly active and negatively charged Streptococcus pyogenes lysin with a rare D-alanyl-L-alanine endopeptidase activity protects mice against streptococcal bacteremia.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A highly active and negatively ...... inst streptococcal bacteremia.
@ast
A highly active and negatively ...... inst streptococcal bacteremia.
@en
type
label
A highly active and negatively ...... inst streptococcal bacteremia.
@ast
A highly active and negatively ...... inst streptococcal bacteremia.
@en
prefLabel
A highly active and negatively ...... inst streptococcal bacteremia.
@ast
A highly active and negatively ...... inst streptococcal bacteremia.
@en
P2093
P2860
P356
P1476
A highly active and negatively ...... inst streptococcal bacteremia.
@en
P2093
Chad W Euler
Henrik Molina
Vincent A Fischetti
P2860
P304
P356
10.1128/AAC.00115-14
P407
P577
2014-03-17T00:00:00Z